Hallucinogen-Persisting Perception Disorder in a 16-Year-Old Adolescent.
Anna Mori-Kreiner, Arpit Aggarwal, Meelie Bordoloi
Psychopharmacology Bulletin February 3, 2025 DOI: 10.1016/j.biopha.2021.112295 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | 16-year-old male with major depressive disorder and polysubstance use |
| Intervention | Aripiprazole |
| Dose | 5 mg |
| Duration | 5-day inpatient admission |
| Keywords | Hallucinogen-persisting perception disorder Hallucinogenic use Mental illness Polysubstance use Flashback disorder Teen mental health Hallucinogen toxicity |
| Citations | 8 |
| Key findings | Aripiprazole 5 mg produced gradual improvement in HPPD symptoms in an adolescent patient, though symptoms did not fully resolve during hospitalization. |
Abstract
Hallucinogen-persisting Perception Disorder (HPPD) is a rare condition characterized by the re-experiencing of one or more perceptual symptoms that an individual experienced while intoxicated with a hallucinogenic substance when the individual is sober. While there are several case reports of HPPD in adult patients, there is a scarcity of documented cases in children and adolescents. The purpose of this article is to highlight the presentation, diagnosis, and treatment of HPPD in a 16-year-old male patient. In this case report, the patient is a 16-year-old male with a history of major depressive disorder (MDD) and polysubstance use using Lysergic acid diethylamide (LSD), 3,4-Methylenedioxymethamphetamine (MDMA), psilocybin, cannabis, and benzodiazepines. He endorsed having auditory hallucinations and a heightened sense of hearing in between usage of MDMA for the past eight months and described auditory and visual hallucinations during his 5-day admission at the inpatient child psychiatric unit. Aripiprazole 5 mg was used as treatment for HPPD. On review of literature, the first-line treatment for HPPD with clonidine and benzodiazepine has been documented by few case reports. Second generation antipsychotics are documented to be less effective with the exception of aripiprazole. The authors witnessed gradual improvement in the patient's symptoms with the use of aripiprazole, although it was not completely resolved during his hospital course. This case demonstrates the presentation of HPPD and efficacy of aripiprazole in an adolescent patient. The diagnosis was further complicated by the patient's history of polysubstance use, and determining a distinction from non-substance-induced psychotic disorders was paramount.
Citations in the library
Cited by 4
- Novel psychoactive substances (NPS) as a risk factor for psychosis: A systematic review of the literature Neuroscience & Biobehavioral Reviews October 19, 2025
- Acute Effects of the Psychedelic Phenethylamine 25I-NBOMe in C57BL/6J Male Mice. International Journal of Molecular Sciences March 20, 2025
- Association of Hallucinogen Persisting Perception Disorder with Trait Neuroticism and Mental Health Symptoms. Journal of Psychoactive Drugs 2025
- Psychedelic-Associated Depersonalization-Derealization Disorder. Current Topics in Behavioral Neurosciences 2026
Cites 16
- Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations Journal of Neuroscience June 19, 2013
- The Therapeutic Value of Lysergic Acid Diethylamide in Mental Illness Journal of Mental Science April 1, 1954
- Visual Phenomenology of the LSD Flashback Archives of General Psychiatry August 1, 1983
- Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives Brain Sciences March 16, 2018
- Designer drugs 2015: assessment and management Addiction Science & Clinical Practice March 11, 2015
and 11 more in the library